Nalaganje...
A Randomized Study of 2 Dose Levels of Intravenous Clofarabine in the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome
BACKGROUND: Clofarabine is a nucleoside analog with activity in myeloid malignancies. Experience in myelodysplastic syndrome (MDS) is limited. METHODS: The goal of this study was to evaluate the activity and safety of 2 different doses (15 mg/m(2) vs 30 mg/m(2) daily×5 days) of intravenous clofarabi...
Shranjeno v:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4180241/ https://ncbi.nlm.nih.gov/pubmed/21751197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26327 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|